By Plenary Sessions: Irja Lutsar

Favors the efficient use of healthcare system resources and cost savings achieved through the consolidation of services, while noting a shortfall of 150 million euros. It opposes lowering the VAT, instead proposing stronger price negotiations with the pharmaceutical industry (including via international cooperation) as an alternative for high-priced medicines.

Economic perspectives advocate for workforce flexibility and partial work during illness. This approach aims to prevent the loss of valuable employees while ensuring the worker retains 100% of their income. The fiscal benefit for the Health Insurance Fund is highlighted, as the compensation rate would drop from 70% to 50%, thereby supporting cost savings.